tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DRTS Stock Latest News

Alpha Tau downgraded to Neutral from Overweight at Piper Sandler
The FlyAlpha Tau downgraded to Neutral from Overweight at Piper Sandler
5d ago
DRTS
DRTS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
DRTS Earnings this Week: How Will it Perform?
6d ago
DRTS
Alpha Tau Lands First International Approval as Japan Grants Marketing Clearance for Alpha DaRT (NASDAQ: DRTS)
PremiumTipRanks Newswire
Alpha Tau Lands First International Approval as Japan Grants Marketing Clearance for Alpha DaRT (NASDAQ: DRTS)
12d ago
DRTS
Alpha Tau price target raised to $12 from $9 at H.C. Wainwright
PremiumThe Fly
Alpha Tau price target raised to $12 from $9 at H.C. Wainwright
12d ago
DRTS
Alpha Tau Wins First Overseas Approval as Japan Clears Alpha DaRT Cancer Therapy
PremiumCompany Announcements
Alpha Tau Wins First Overseas Approval as Japan Clears Alpha DaRT Cancer Therapy
13d ago
6K
DRTS
Alpha Tau announces Japan’s MHLW granted marketing approbal for Alpha DaRT
PremiumThe FlyAlpha Tau announces Japan’s MHLW granted marketing approbal for Alpha DaRT
13d ago
DRTS
Alpha Tau Outlines Aggressive 2026 Clinical Schedule and Manufacturing Ramp for Alpha DaRT Cancer Therapy
Premium
Company Announcements
Alpha Tau Outlines Aggressive 2026 Clinical Schedule and Manufacturing Ramp for Alpha DaRT Cancer Therapy
1M ago
6K
DRTS
Alpha Tau issues letter to shareholders
Premium
The Fly
Alpha Tau issues letter to shareholders
1M ago
DRTS
Alpha Tau Medical Unveils Strong Pancreatic Cancer Alpha DaRT Data Ahead of ASCO GI 2026
PremiumCompany Announcements
Alpha Tau Medical Unveils Strong Pancreatic Cancer Alpha DaRT Data Ahead of ASCO GI 2026
2M ago
6K
DRTS
Alpha Tau announces release of final results from study of Alpha DaRT
PremiumThe Fly
Alpha Tau announces release of final results from study of Alpha DaRT
2M ago
DRTS
Advancing Alpha DaRT: Regulatory Momentum, Pipeline Expansion, and Favorable Risk–Reward Support Buy Rating on Alpha Tau Medical
PremiumRatings
Advancing Alpha DaRT: Regulatory Momentum, Pipeline Expansion, and Favorable Risk–Reward Support Buy Rating on Alpha Tau Medical
2M ago
DRTS
Alpha Tau Files First FDA PMA Module for Alpha DaRT Skin Cancer Therapy
PremiumCompany Announcements
Alpha Tau Files First FDA PMA Module for Alpha DaRT Skin Cancer Therapy
2M ago
6K
DRTS
Alpha Tau submits PMA module to FDA for Alpha DaRT
PremiumThe FlyAlpha Tau submits PMA module to FDA for Alpha DaRT
2M ago
DRTS
Alpha Tau Expands Alpha DaRT Into Recurrent Prostate Cancer: What Investors Should Watch
Premium
Company Announcements
Alpha Tau Expands Alpha DaRT Into Recurrent Prostate Cancer: What Investors Should Watch
3M ago
DRTS
Alpha Tau Medical to Present Corporate Update at J.P. Morgan 2026 Healthcare Conference
Premium
Company Announcements
Alpha Tau Medical to Present Corporate Update at J.P. Morgan 2026 Healthcare Conference
3M ago
6K
DRTS
Alpha Tau Medical’s Innovative Prostate Cancer Therapy: Study Completion Update
PremiumCompany Announcements
Alpha Tau Medical’s Innovative Prostate Cancer Therapy: Study Completion Update
3M ago
DRTS
Alpha Tau Medical’s Innovative Cancer Treatment Study Update: A Potential Game-Changer
PremiumCompany Announcements
Alpha Tau Medical’s Innovative Cancer Treatment Study Update: A Potential Game-Changer
3M ago
DRTS
Promising Clinical Developments and Innovative Technology Drive Buy Rating for Alpha Tau Medical Ltd
PremiumRatings
Promising Clinical Developments and Innovative Technology Drive Buy Rating for Alpha Tau Medical Ltd
3M ago
DRTS
Alpha Tau price target lowered to $7 from $8 at Citi
PremiumThe Fly
Alpha Tau price target lowered to $7 from $8 at Citi
3M ago
DRTS
Optimistic Growth Prospects and Strategic Developments Drive Buy Rating for Alpha Tau Medical Ltd
PremiumRatingsOptimistic Growth Prospects and Strategic Developments Drive Buy Rating for Alpha Tau Medical Ltd
3M ago
DRTS
Alpha Tau Treats First U.S. Patient with Alpha DaRT for Glioblastoma
Premium
Company Announcements
Alpha Tau Treats First U.S. Patient with Alpha DaRT for Glioblastoma
3M ago
6K
DRTS
Alpha Tau announces first patient treated in study using Alpha DaRT tech
Premium
The Fly
Alpha Tau announces first patient treated in study using Alpha DaRT tech
3M ago
DRTS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >